Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Adenosine triphosphate injection - Cordex Pharma

Drug Profile

Adenosine triphosphate injection - Cordex Pharma

Alternative Names: ATPace

Latest Information Update: 29 Jul 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Duska Therapeutics
  • Developer Cordex Pharma
  • Class Adenine nucleotides; Antiarrhythmics; Diagnostic agents; Infertility therapies; Small molecules
  • Mechanism of Action Purinergic P2 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Bradycardia; Paroxysmal supraventricular tachycardia

Most Recent Events

  • 02 Jun 2009 The US FDA approves Special Protocol Assessment (SPA) design of phase IIb/III trials for Paroxysmal supraventricular tachycardia
  • 20 Feb 2009 Cordex Pharma submits to the US FDA an amended phase III trial protocol for Paroxysmal supraventricular tachycardia
  • 20 Nov 2008 Duska Therapeutics applies for a Special Protocol Assessment with the US FDA to conduct a pivotal phase III trial for Paroxysmal supraventricular tachycardia
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top